How do beta-agonists function as bronchodilators?

• A. Inhibit acetylcholine release
• B. Activate beta-2 adrenergic receptors
• C. Block histamine receptors
• D. Inhibit leukotriene production

Answer: (B)

Beta-agonists function as bronchodilators primarily by activating beta-2 adrenergic receptors located in the smooth muscles of the airways. When these receptors are stimulated, they cause relaxation of the bronchial smooth muscle, which leads to dilation of the airways. This dilation reduces airway resistance and improves airflow, making it easier for individuals with conditions such as asthma or chronic obstructive pulmonary disease (COPD) to breathe.

The mechanism of action is specific to the beta-2 receptors, which are predominantly found in the lung tissue, distinguishing them from other adrenergic receptors that might lead to different physiological effects. By selectively acting on these receptors, beta-agonists can effectively provide relief from bronchospasm without significant effects on other systems, which is particularly important in managing respiratory conditions.

In contrast, other options listed do not directly contribute to the bronchodilation process. For instance, inhibiting acetylcholine release or blocking histamine receptors may have roles in respiratory function or inflammation but do not facilitate the direct relaxation of bronchial smooth muscle like beta-2 activation does. Similarly, inhibiting leukotriene production is related to reducing inflammation rather than directly causing bronchodilation. Therefore, the selective activation of beta-2 adrenerg